Form 8-K - Current report:
SEC Accession No. 0001570562-21-000147
Filing Date
2021-08-04
Accepted
2021-08-04 16:12:50
Documents
14
Period of Report
2021-08-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K eols-20210804.htm   iXBRL 8-K 34114
2 EX-99.1 q22021eolsex991.htm EX-99.1 159739
6 evoluslogohorizontal.jpg GRAPHIC 270362
  Complete submission text file 0001570562-21-000147.txt   699962

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT eols-20210804.xsd EX-101.SCH 1909
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT eols-20210804_lab.xml EX-101.LAB 24831
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT eols-20210804_pre.xml EX-101.PRE 13051
7 EXTRACTED XBRL INSTANCE DOCUMENT eols-20210804_htm.xml XML 11028
Mailing Address 520 NEWPORT CENTER DRIVE SUITE 1200 NEWPORT BEACH CA 92660
Business Address 520 NEWPORT CENTER DRIVE SUITE 1200 NEWPORT BEACH CA 92660 (949) 284-4555
Evolus, Inc. (Filer) CIK: 0001570562 (see all company filings)

EIN.: 461385614 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38381 | Film No.: 211144153
SIC: 2834 Pharmaceutical Preparations